Showing 35,658 results

People with limited treatment options

TMC114 appears to be strong PI option for salvage therapy

News
28 February 2005
Side effects

Myocardial infarction risk rises with each year of antiretroviral therapy, but remains low

News
28 February 2005
People with limited treatment options

Investigational NNRTI TMC278 swiftly cuts viral load in treatment-naive patients

News
27 February 2005
HIV treatment

Vanguard treatment programmes pave the way to scale up

News
27 February 2005
Treatment interruptions

Therapeutic vaccine plus interleukin-2 shows best viral control in treatment breaks

News
27 February 2005
Transmission & prevention

Pre-exposure prophylaxis may only offer limited benefit

News
27 February 2005
Resistance

Little difference in child transmission rates between formula feed and breast-plus-AZT

News
26 February 2005
New & experimental HIV treatments

Two new drug classes given to people with HIV for the first time

News
26 February 2005

Three trials bring African mother to child transmission down to four per cent; WHO vows to reconsider guidelines

News
26 February 2005
TB treatment

Six- and nine-month courses of TB treatment equivalent in Indian HIV-positive patients

News
26 February 2005
Side effects

Pregnant women with CD4 cell counts over 250 not at greater risk of nevirapine-related toxicity in Kenyan study

News
26 February 2005
Epidemiology

MRSA in HIV-positive patients often community acquired, associated with HIV disease severity

News
26 February 2005
Side effects

Therapeutic range for atazanavir defined

News
26 February 2005

Therapeutic drug monitoring useful for improving treatment outcomes in many patients taking HAART

News
26 February 2005
Pregnancy, children & young people

Single-dose nevirapine reduces HIV transmission in second delivery

News
25 February 2005

Pregnancy doubles the risk of HIV infection

News
25 February 2005
Resistance

Highly sensitive method uncovers high levels of resistance in mothers given single-dose nevirapine

News
25 February 2005
Starting treatment

Long-term CD4 increase on HAART averages 250-350 cells, plateaus after 3-4 years

News
25 February 2005
Changing treatment

Switch to tenofovir better than change to abacavir?

News
25 February 2005
People with limited treatment options

Addition of capravirine to a three-drug regimen not beneficial in patients with NNRTI resistance

News
25 February 2005
Transmission & prevention

The ‘New York case’: details revealed at Boston conference

News
25 February 2005
Side effects

Fish oils can reverse high blood lipids caused by antiretrovirals

News
24 February 2005
Transmission & prevention

D for death, not A B or C, is main cause of decline in Ugandan HIV prevalence

News
24 February 2005
Pregnancy, children & young people

NNRTI-based HAART effective in Thai children

News
24 February 2005